SUN Pharmaceutical Industries Limited — Liraglutide Exporter Profile
Indian Pharmaceutical Exporter · #1 for Liraglutide · $750.0K export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #1 Indian exporter of Liraglutide with $750.0K in export value and 15 verified shipments. SUN Pharmaceutical Industries Limited holds a 17.5% market share in Liraglutide exports across 4 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Liraglutide Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Liraglutide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $350.0K | 7 | 100.0% |
| RUSSIA | $60 | 3 | 0.0% |
| KENYA | $9 | 2 | 0.0% |
| HUNGARY | $8 | 3 | 0.0% |
SUN Pharmaceutical Industries Limited exports Liraglutide to 4 countries. The largest destination is BELGIUM accounting for 100.0% of SUN Pharmaceutical Industries Limited's Liraglutide shipments, followed by RUSSIA (0.0%) and KENYA (0.0%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Liraglutide from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $350.0K | 7 |
| NOVOCHEMIX BIOMEDIC LLC | RUSSIA | $60 | 3 |
| SUN PHARMA EAST AFRICA LTD. | KENYA | $9 | 2 |
| ALKALOIDA CHEMICAL COMPANY ZRT. | HUNGARY | $8 | 3 |
SUN Pharmaceutical Industries Limited supplies Liraglutide to 4 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by NOVOCHEMIX BIOMEDIC LLC (RUSSIA) and SUN PHARMA EAST AFRICA LTD. (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Liraglutide Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $2.7M worth of Liraglutide through 416 shipments from 53 suppliers to 36 countries, serving 121 buyers globally. SUN Pharmaceutical Industries Limited contributes $750.0K to this total, accounting for 17.5% of India's Liraglutide exports. SUN Pharmaceutical Industries Limited ships Liraglutide to 4 countries through 4 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Liraglutide Exports?
SUN Pharmaceutical Industries Limited's average Liraglutide shipment value is $50.0K per consignment, based on 15 shipments totaling $750.0K. The largest destination is BELGIUM (100.0% of SUN Pharmaceutical Industries Limited's Liraglutide exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Liraglutide Exporters?
SUN Pharmaceutical Industries Limited ranks #1 among 53 Indian Liraglutide exporters with a 17.5% market share. The top 3 exporters are ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI ($1.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($750.0K), LUPIN LIMITED ($35.4K). SUN Pharmaceutical Industries Limited processed 15 shipments to 4 destination countries.
What Liraglutide Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DIAVIC INJ 6MG/ML 2X1'S PEN NL (LIRAGLUTIDE 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN)-GST INVOICE NO | $100.0K | 2 |
| LIRAGLUTIDE 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN (Diavic Inj 6mg/ml 3x1'S Pen UK)-GST INVOICE NO | $50.0K | 1 |
| LIRAGLUTIDE 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN (DiavicInj 6mg/ml 2x1'S Pen UK)-GST INVOICE NO | $50.0K | 1 |
| DIAVIC INJ 6MG/ML 3X1'S PEN SE (LIRAGLUTIDE 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN)-GST INVOICE NO | $50.0K | 1 |
| BYESILOR INJECTION 6MG/ML (LIRAGLUTIDE 6MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN) [2589 PACK X 5X1] | $50.0K | 1 |
| DIAVIC INJECTION 6MG/ML (LIRAGLUTIDE 6MG/ML SOLUTION FOR INJECTION IN PRE-FILLEDPEN) [1304 PACK X 1X10'S] | $50.0K | 1 |
| RALITUDE(LIRAGLUTIDE 6MG/MLSOLUTION FOR INJ.IN PRE-FILLED PEN59 PACKS(118 PENSX3ML) | $25 | 1 |
| LIRATOZA(LIRAGLUTIDE 6MG/MLSOLUTION FOR INJ.IN PRE-FILLED PEN59 PACKS(118 PENSX3ML) | $25 | 1 |
| PLACEBO FOR LIRAGLUTIDE INJ.10 PACKS20 PENSX3ML) | $10 | 1 |
| LISURE (Liraglutide 6mg/ml solution forinjection in pre-filled Pen, 3ml) | $9 | 2 |
SUN Pharmaceutical Industries Limited exports 13 distinct Liraglutide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DIAVIC INJ 6MG/ML 2X1'S PEN NL (LIRAGLUTIDE 6 MG/ML SOLUTION with 2 shipments worth $100.0K.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Liraglutide Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI | $1.9M | 91 | 9 | $20.6K |
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $750.0K | 15 | 4 | $50.0K |
| 3 | LUPIN LIMITED | $35.4K | 10 | 3 | $3.5K |
| 4 | ABBOTT INDIA LIMITED | $20.0K | 5 | 1 | $4.0K |
SUN Pharmaceutical Industries Limited ranks #1 among 53 Indian Liraglutide exporters. Average shipment value of $50.0K compared to the market average of $51.4K. The closest competitors by value are ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI and LUPIN LIMITED.
Which Indian Ports Ship Liraglutide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 85 | 20.4% |
| HYDERABAD ACC (INHYD4) | 76 | 18.3% |
| HYDERABAD AIR | 66 | 15.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 31 | 7.5% |
| HAZIRA PORT SURAT ICD | 31 | 7.5% |
| AHEMDABAD AIR | 18 | 4.3% |
| BANGALORE AIR | 18 | 4.3% |
| Hyderabad Air | 9 | 2.2% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Liraglutide Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Liraglutide, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Liraglutide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Liraglutide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 15 individual customs records matching SUN Pharmaceutical Industries Limited exporting Liraglutide, covering 13 formulations to 4 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 36+ countries, 121+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Liraglutide Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Liraglutide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Liraglutide Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Liraglutide. For current shipment-level data, contact TransData Nexus.